Sexual Quality of Patients After Bladder Cancer Cystectomy

Sexual Quality of Patients After Bladder Cancer Cystectomy : A Prospective Observational Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04964895

Acronym

QSCO

Enrollment

Registered

2021-07-16

Start date

2021-09-20

Completion date

2023-01-01

Last updated

2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Dysfunction

Keywords

bladder cancer, cystectomy, sex life, sex quality

Brief summary

Bladder cancer is the second most prevalent urological cancer in France. About 1 in 5 new cases of bladder cancer infiltrate the muscles. The standard treatment is neoadjuvant chemotherapy followed by radical cystectomy associated with reconstruction of the urinary tract. The short-term effects on well-being and quality of life are well known. The long-term effects are, on the other hand, poorly understood, particularly sexual function. This study aim to asses the quality of sexual life in patients with cystectomy for bladder cancer. This will be done via various questionnaires given before and after surgery.

Detailed description

The study is a prospective observational cohort study of the quality of sexual life in patients with cystectomy for bladder cancer. Data is collected via Qlq-C30, EORTC-Shq22, MSHQ if male, Female Sexual Function Index (FSFI) questionnaires that the patients complete by themselves. They are given before surgery and then 8 months after surgery. The study consists of the compilation of relevant clinical data and questionnaire results.

Interventions

OTHERQuestionnaires

Patients will fill in multiple questionnaires for this study : EORTC quality of life questionnaire (QLQ) QLQ-C30, EORTC Shq22, Male Sexual Health Questionnaire (MSHQ) only for Men, FSFI (only for women)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Any adult patient who had a cystectomy for bladder cancer * Affiliated with a social security scheme

Exclusion criteria

* No Cystectomy * Cystectomy for neurological etiology * Pregnant or breastfeeding women

Design outcomes

Primary

Measure	Time frame	Description
Evaluation of the decrease in the quality of sexual life of patients who had a cystectomy	T0 : before surgery	EORTC SHQ C22 score before surgery

Secondary

Measure	Time frame	Description
Evaluation of the decrease in the quality of life of patients who had a cystectomy	T0 : before surgery	QLQ-C30 score before surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026